Aggregation Mechanism of Alzheimer's Amyloid β-Peptide Mediated by α-Strand/α-Sheet Structure

• Published in: International journal of molecular sciences 2020-02, Vol.21 (3), p.1094
• Main Authors: Balupuri, Anand, Choi, Kwang-Eun, Kang, Nam Sook
• Format: Article
• Language: English
• Subjects: Alzheimer's disease; amyloid-β peptide; Clinical trials; Conformation; Cytotoxicity; Dementia disorders; Drug development; Fibrillation; High temperature; Hydrogen bonding; Hypotheses; md simulation; Molecular dynamics; Mutation; Peptides; Pharmaceutical industry; Physiology; Polymerization; Proteins; Simulation; Toxicity; α-sheet; α-strand; β-Amyloid
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms21031094

Alzheimer's disease (AD) is one of the most common neurodegenerative diseases and a widespread form of dementia. Aggregated forms of the amyloid β-peptide (Aβ) are identified as a toxic species responsible for neuronal damage in AD. Extensive research has been conducted to reveal the aggregation mechanism of Aβ. However, the structure of pathological aggregates and the mechanism of aggregation are not well understood. Recently, experimental studies have confirmed that the α-sheet structure in Aβ drives aggregation and toxicity in AD. However, how the α-sheet structure is formed in Aβ and how it contributes to Aβ aggregation remains elusive. In the present study, molecular dynamics simulations suggest that Aβ adopts the α-strand conformation by peptide-plane flipping. Multiple α-strands interact through hydrogen bonding to form α-sheets. This structure acts as a nucleus that initiates and promotes aggregation and fibrillation of Aβ. Our findings are supported by previous experimental as well as theoretical studies. This study provides valuable structural insights for the design of anti-AD drugs exploiting the α-strand/α-sheet structure.